Efficacy of the Phosphodiesterase-4 Inhibitor, Apremilast, in a Patient with Severe Alopecia Areata

The document discussed the use of apremilast, a phosphodiesterase-4 inhibitor, in treating a patient with severe alopecia areata (AA), an autoimmune disease that causes hair loss. Traditional treatments for extensive AA, such as steroids and phototherapy, often lacked sustained efficacy and had multiple side effects. The study highlighted the need for more effective and safer treatment strategies, noting that previous research identified the Th1 pathway as crucial in AA. However, the document did not provide specific results or conclusions regarding the efficacy of apremilast in this particular case.